Related Experiment Video
Updated: Jun 10, 2025

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma
Published on: March 30, 2018
Differentiating between Lymphoma and Metastasis Presenting as Solid Cerebellar Mass Lacking Necrosis.
Gye Ryeong Park1, Byung Hyun Baek1, Seul Kee Kim2
1Department of Radiology, Chonnam National University Medical School, Chonnam National University Hospital, Gwangju 61469, Republic of Korea.
The serrate sign on MRI can help distinguish primary central nervous system lymphoma (PCNSL) from cerebellar metastasis. This imaging feature, along with homogeneous enhancement, is key for accurate diagnosis.
Area of Science:
- Radiology
- Neurology
- Oncology
Background:
- Differentiating cerebellar masses between primary central nervous system lymphoma (PCNSL) and metastasis is clinically important.
- Solid enhancing cerebellar masses lacking necrosis present a diagnostic challenge.
Purpose of the Study:
- To identify distinct radiologic features on contrast-enhanced MRI that differentiate PCNSL from metastasis in the cerebellum.
- To evaluate the diagnostic performance of specific imaging signs, including the 'serrate sign'.
Main Methods:
- Retrospective analysis of 24 PCNSL and 32 metastasis cases with solid, non-necrotic, enhancing cerebellar masses.
- Evaluation of imaging characteristics on contrast-enhanced MRI, defining the 'serrate sign' as tumor spread along white matter with branch-like enhancement.
Main Results:
- The serrate sign was exclusively found in PCNSL (75.0%) versus metastasis (0%, p < 0.001).
- Homogeneous enhancement was more frequent in PCNSL (91.7%) compared to metastasis (21.9%, p < 0.001).
- Bulging contour and surface involvement were more indicative of metastasis.
Conclusions:
- The serrate sign and homogeneous enhancement are reliable MRI indicators for differentiating cerebellar PCNSL from metastasis.
- The serrate sign shows high sensitivity (75.0%) and specificity (100%) for PCNSL detection.
More Related Videos
08:57Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
Published on: May 17, 2024
06:25Author Spotlight: Assessing the Potential of Circulating Tumor Cells in Leptomeningeal Disease Research
Published on: March 29, 2024